×
Trends in Office-Based Treatment of Adults With Stimulants in the United States PDF
$ 40.00
Trends in Office-Based Treatment of Adults With Stimulants in the United States PDF quantity
$ 40.00
×
Suicide Attempts Among Veterans Seeking Treatment for Pathological Gambling PDF
$ 40.00
Suicide Attempts Among Veterans Seeking Treatment for Pathological Gambling PDF quantity
$ 40.00
×
What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder? PDF
$ 40.00
What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder? PDF quantity
$ 40.00
×
Causes of Aggressive Behavior in Patients With Dementia PDF
$ 40.00
Causes of Aggressive Behavior in Patients With Dementia PDF quantity
$ 40.00
×
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF
$ 40.00
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Third Generation Anticonvulsants in Bipolar Disorder: A Review of Efficacy and Summary of Clinical Recommendations PDF
$ 40.00
Third Generation Anticonvulsants in Bipolar Disorder: A Review of Efficacy and Summary of Clinical Recommendations PDF quantity
$ 40.00
×
Choice of Antipsychotic in HIV-Infected Patients PDF
$ 40.00
Choice of Antipsychotic in HIV-Infected Patients PDF quantity
$ 40.00
×
Sertraline Versus Paroxetine in the Treatment of Panic Disorder: An Acute, Double-Blind Noninferiority Comparison PDF
$ 40.00
Sertraline Versus Paroxetine in the Treatment of Panic Disorder: An Acute, Double-Blind Noninferiority Comparison PDF quantity
$ 40.00
×
Risperidone, 2 mg/day vs. 4 mg/day, in First-Episode, Acutely Psychotic Patients: Treatment Efficacy and Effects on Fine Motor Functioning PDF
$ 40.00
Risperidone, 2 mg/day vs. 4 mg/day, in First-Episode, Acutely Psychotic Patients: Treatment Efficacy and Effects on Fine Motor Functioning PDF quantity
$ 40.00
×
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Methylphenidate Transdermal System in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder PDF
$ 40.00
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Methylphenidate Transdermal System in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder PDF quantity
$ 40.00
×
Impact of Prenatal Exposure to Serotonin Reuptake Inhibitors or Maternal Major Depressive Disorder on Infant Developmental Outcomes PDF
$ 40.00
Impact of Prenatal Exposure to Serotonin Reuptake Inhibitors or Maternal Major Depressive Disorder on Infant Developmental Outcomes PDF quantity
$ 40.00
×
Long-Acting Injectable Antipsychotics for Schizophrenia: Sociodemographic Characteristics and Treatment Adherence PDF
$ 40.00
Long-Acting Injectable Antipsychotics for Schizophrenia: Sociodemographic Characteristics and Treatment Adherence PDF quantity
$ 40.00
×
Shorter- and Longer-Term Risk for Suicide Among Male US Military Veterans in the Year After Discharge From Psychiatric Hospitalization PDF
$ 40.00
Shorter- and Longer-Term Risk for Suicide Among Male US Military Veterans in the Year After Discharge From Psychiatric Hospitalization PDF quantity
$ 40.00
×
Lithium Beyond Bipolar Mood Disorders: A Hope or Hype? PDF
$ 40.00
Lithium Beyond Bipolar Mood Disorders: A Hope or Hype? PDF quantity
$ 40.00
×
Effectiveness and Feasibility of a Standardized Stepwise Drug Treatment Regimen Algorithm for Inpatients With Depressive Disorders: Results of a 2-Year Observational Algorithm Study. PDF
$ 40.00
Effectiveness and Feasibility of a Standardized Stepwise Drug Treatment Regimen Algorithm for Inpatients With Depressive Disorders: Results of a 2-Year Observational Algorithm Study. PDF quantity
$ 40.00
×
Review of the Safety of Second-Generation Antipsychotics: Are They Really "Atypically" Safe for Youth and Adults? PDF
$ 40.00
Review of the Safety of Second-Generation Antipsychotics: Are They Really "Atypically" Safe for Youth and Adults? PDF quantity
$ 40.00
×
Paroxetine in the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled, Flexible-Dosage Trial PDF
$ 40.00
Paroxetine in the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled, Flexible-Dosage Trial PDF quantity
$ 40.00
×
Use of Clinical Markers to Identify Metabolic Syndrome in Antipsychotic-Treated Patients PDF
$ 40.00
Use of Clinical Markers to Identify Metabolic Syndrome in Antipsychotic-Treated Patients PDF quantity
$ 40.00
×
Characteristics of E-Therapy Web Sites PDF
$ 40.00
Characteristics of E-Therapy Web Sites PDF quantity
$ 40.00
×
How to Live With a Terminal Illness PDF
$ 40.00
How to Live With a Terminal Illness PDF quantity
$ 40.00
×
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder PDF
$ 40.00
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart